198 related articles for article (PubMed ID: 11570815)
1. The A3 adenosine receptor as a new target for cancer therapy and chemoprotection.
Fishman P; Bar-Yehuda S; Barer F; Madi L; Multani AS; Pathak S
Exp Cell Res; 2001 Oct; 269(2):230-6. PubMed ID: 11570815
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of cell proliferation through cell cycle arrest and apoptosis by thio-Cl-IB-MECA, a novel A3 adenosine receptor agonist, in human lung cancer cells.
Kim SJ; Min HY; Chung HJ; Park EJ; Hong JY; Kang YJ; Shin DH; Jeong LS; Lee SK
Cancer Lett; 2008 Jun; 264(2):309-15. PubMed ID: 18321638
[TBL] [Abstract][Full Text] [Related]
3. Suppression of inflammation response by a novel A₃ adenosine receptor agonist thio-Cl-IB-MECA through inhibition of Akt and NF-κB signaling.
Lee HS; Chung HJ; Lee HW; Jeong LS; Lee SK
Immunobiology; 2011 Sep; 216(9):997-1003. PubMed ID: 21514967
[TBL] [Abstract][Full Text] [Related]
4. Differential effect of adenosine on tumor and normal cell growth: focus on the A3 adenosine receptor.
Ohana G; Bar-Yehuda S; Barer F; Fishman P
J Cell Physiol; 2001 Jan; 186(1):19-23. PubMed ID: 11147810
[TBL] [Abstract][Full Text] [Related]
5. Adenosine acts as a chemoprotective agent by stimulating G-CSF production: a role for A1 and A3 adenosine receptors.
Fishman P; Bar-Yehuda S; Farbstein T; Barer F; Ohana G
J Cell Physiol; 2000 Jun; 183(3):393-8. PubMed ID: 10797314
[TBL] [Abstract][Full Text] [Related]
6. Targeting the A3 adenosine receptor for cancer therapy: inhibition of prostate carcinoma cell growth by A3AR agonist.
Fishman P; Bar-Yehuda S; Ardon E; Rath-Wolfson L; Barrer F; Ochaion A; Madi L
Anticancer Res; 2003; 23(3A):2077-83. PubMed ID: 12894581
[TBL] [Abstract][Full Text] [Related]
7. A3 adenosine receptor as a target for cancer therapy.
Fishman P; Bar-Yehuda S; Madi L; Cohn I
Anticancer Drugs; 2002 Jun; 13(5):437-43. PubMed ID: 12045454
[TBL] [Abstract][Full Text] [Related]
8. Activation of adenosine A(3) receptors supports hematopoiesis-stimulating effects of granulocyte colony-stimulating factor in sublethally irradiated mice.
Hofer M; Pospísil M; Sefc L; Dusek L; Vacek A; Holá J; Hoferová Z; Streitová D
Int J Radiat Biol; 2010 Aug; 86(8):649-56. PubMed ID: 20586541
[TBL] [Abstract][Full Text] [Related]
9. An adenosine analogue, IB-MECA, down-regulates estrogen receptor alpha and suppresses human breast cancer cell proliferation.
Lu J; Pierron A; Ravid K
Cancer Res; 2003 Oct; 63(19):6413-23. PubMed ID: 14559831
[TBL] [Abstract][Full Text] [Related]
10. Adenosine inhibits macrophage colony-stimulating factor-dependent proliferation of macrophages through the induction of p27kip-1 expression.
Xaus J; Valledor AF; Cardó M; Marquès L; Beleta J; Palacios JM; Celada A
J Immunol; 1999 Oct; 163(8):4140-9. PubMed ID: 10510349
[TBL] [Abstract][Full Text] [Related]
11. Homeostatic action of adenosine A3 and A1 receptor agonists on proliferation of hematopoietic precursor cells.
Hofer M; Pospísil M; Znojil V; Holá J; Streitová D; Vacek A
Exp Biol Med (Maywood); 2008 Jul; 233(7):897-900. PubMed ID: 18445770
[TBL] [Abstract][Full Text] [Related]
12. Induction of apoptosis in cardiac myocytes by an A3 adenosine receptor agonist.
Shneyvays V; Nawrath H; Jacobson KA; Shainberg A
Exp Cell Res; 1998 Sep; 243(2):383-97. PubMed ID: 9743598
[TBL] [Abstract][Full Text] [Related]
13. Cl-IB-MECA enhances TRAIL-induced apoptosis via the modulation of NF-kappaB signalling pathway in thyroid cancer cells.
Morello S; Sorrentino R; Porta A; Forte G; Popolo A; Petrella A; Pinto A
J Cell Physiol; 2009 Nov; 221(2):378-86. PubMed ID: 19562684
[TBL] [Abstract][Full Text] [Related]
14. Effects of adenosine A(3) receptor agonist on bone marrow granulocytic system in 5-fluorouracil-treated mice.
Hofer M; Pospísil M; Vacek A; Holá J; Znojil V; Weiterová L; Streitová D
Eur J Pharmacol; 2006 May; 538(1-3):163-7. PubMed ID: 16643889
[TBL] [Abstract][Full Text] [Related]
15. Adenosine receptors in colon carcinoma tissues and colon tumoral cell lines: focus on the A(3) adenosine subtype.
Gessi S; Merighi S; Varani K; Cattabriga E; Benini A; Mirandola P; Leung E; Mac Lennan S; Feo C; Baraldi S; Borea PA
J Cell Physiol; 2007 Jun; 211(3):826-36. PubMed ID: 17348028
[TBL] [Abstract][Full Text] [Related]
16. Adenosine A3 receptor-induced CCL2 synthesis in cultured mouse astrocytes.
Wittendorp MC; Boddeke HW; Biber K
Glia; 2004 May; 46(4):410-8. PubMed ID: 15095371
[TBL] [Abstract][Full Text] [Related]
17. An adenosine analog (IB-MECA) inhibits anchorage-dependent cell growth of various human breast cancer cell lines.
Panjehpour M; Karami-Tehrani F
Int J Biochem Cell Biol; 2004 Aug; 36(8):1502-9. PubMed ID: 15147729
[TBL] [Abstract][Full Text] [Related]
18. P-glycoprotein mediates resistance to A3 adenosine receptor agonist 2-chloro-N6-(3-iodobenzyl)-adenosine-5'-n-methyluronamide in human leukemia cells.
Mlejnek P; Dolezel P; Kosztyu P
J Cell Physiol; 2012 Feb; 227(2):676-85. PubMed ID: 21520073
[TBL] [Abstract][Full Text] [Related]
19. Adenosine A(3) receptor agonist acts as a homeostatic regulator of bone marrow hematopoiesis.
Hofer M; Pospísil M; Znojil V; Holá J; Vacek A; Streitová D
Biomed Pharmacother; 2007 Jul; 61(6):356-9. PubMed ID: 17383145
[TBL] [Abstract][Full Text] [Related]
20. Mast cell-mediated stimulation of angiogenesis: cooperative interaction between A2B and A3 adenosine receptors.
Feoktistov I; Ryzhov S; Goldstein AE; Biaggioni I
Circ Res; 2003 Mar; 92(5):485-92. PubMed ID: 12600879
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
